3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1
2
Phase NA
1
Phase 4
1
Phase 2/3
1
Phase 2
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
18
Breast Neoplasms
15
Pancreatic Neoplasms
13
Colorectal Neoplasms
10
Rectal Neoplasms
7
Stomach Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Neoplasms
5
Recurrence
4
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Small Cell Lung Carcinoma
3
Prostatic Neoplasms
3
Lymphoma, T-Cell, Peripheral
3
Leukemia, Myeloid, Acute
3
Esophageal Squamous Cell Carcinoma
3
Colonic Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Treatment
2
Solid Tumor
2
Small Cell Lung Cancer Limited Stage
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Lymphoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Esophageal Neoplasms
2
Interventions
Surveys and Questionnaires
9
Standard of Care
5
Endoscopic Mucosal Resection
5
Educational Status
5
Blood Specimen Collection
5
Diet Therapy
3
Referral and Consultation
2
Quality of Life
2
Practice Guidelines as Topic
2
Palliative Care
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Control Groups
2
Aprepitant
2
Acceptance and Commitment Therapy
2
vandetanib
1
fosaprepitant
1
dolasetron
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Weights and Measures
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surgical Instruments
1
Sunitinib
1
Sorafenib
1
Sampling Studies
1
Restraint, Physical
1
Remote Patient Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Gastrointestinal Neoplasms
×
Drug Therapy
×
Clear all
NCT02797197
2018-01-08
FIGHTDIGO
CHU de Reims
Phase NA
Completed
201 enrolled